I think it won’t have an impact either way.. Our

I think it won’t have an impact either way.. Our volume over the last 3-4 weeks is very low and I believe the buyers are already in who are aware of Cytodyn .The longs are waiting on Cd12 interim which to me is THE major milestone as of now. The NASDAQ uplist not sure. I just don’t get the feeling it’s coming in at this time . It would be helpful if it did come in because it opens the company up to bigger investors..But back on the call in August the CFO was giving very vague answers to the question to the point I wouldn’t even qualify his comments as answers. Either he wasn’t prepared or he just didn’t have anything concrete that was going on. Just my opinion ..